SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?


To: sense who wrote (173902)6/29/2021 2:18:57 AM
From: TobagoJack  Read Replies (1) | Respond to of 217580
 
India experience might indicate a hint of forward path, that ...

- a lot more cases happened, with many more asymptomatic
- a lot of death, but fatality rate far less than first indicated
- Ivermectin 'apparently' helped

Remaining agnostic and in mode of wait & see.

But if so,
- then either the bioweapons experts in whichever domain responsible did not do a lethal job in gain of function formulation, or

- China, in the early days did not pay attention to a few coughs, or

- whomever the designers of the virus did not figure out as a part of design process that the simplicity of ivermectin is a preventative, and

- in any case a lot of economic domains bum rushed into expensive pathway unnecessarily,

- or something, and a lot of naughty relationships could have continued on and not be caught up in inconvenient virus lockdowns Message 33378853 <<A question>>

he added that the institute estimates India has detected only about 3% to 5% of all infections due to insufficient testing.
Of course, as we noted above, it's not just India. The WHO believes the true number of COVID-19 cases around the world is 2x to 3x higher than the official tally.
At the very least, more communities across India are resorting to COVID prophylactics like Ivermectin, measures that have apparently helped India to finally bring its outbreak under control.
zerohedge.com

India May Have Failed To Count As Many As 1 Million COVID Deaths

With nearly 400K COVID-19 deaths, India has the world's third-highest coronavirus death toll, following the US (in first place with more than 600K+) and Brazil (coming in second with 510K+). For months now, we have been reporting on commentary from analysts and public health experts speculating that India's total COVID deaths might be 2x the official number. Some journalists have even found evidence of deaths that weren't included in the official tally.

On Monday, a story published by WSJ cited modeling from the University of Washington's IHME institute, the not-very-accurate purveyor of COVID-19 forecasting, which suggests that India's COVID-19 death toll might be as high as 1.1MM. This would mean that the wave of infections that spread across India in April and May (largely driven by the Delta variant) may have been the deadliest outbreak yet.

[url=][/url]

Lacking accurate data on deaths is a problem for scientists trying to determine exactly how much deadlier the "Delta" variant is when compared with earlier strains of the virus. An accurate count is "a very important part of understanding how big a threat new variants are," said Christopher Murray, director of the University of Washington’s Institute for Health Metrics and Evaluation.

Dr. Murray believes the scale of under-counting of COVID-linked deaths in India is similar to the scale of under-counting seen in Africa and Latin America. But even greater than the under-counting of deaths, of course, is the under-counting of total cases, he added that the institute estimates India has detected only about 3% to 5% of all infections due to insufficient testing.

Another academic believes COVID deaths in India might be as much as 5x higher than the current tally, which would place the death toll closer to 2MM. That's according to Murad Banaji, a mathematician at the Middlesex University in London who has been tracking the pandemic in India, estimates the country’s real death toll could be around 5x the reported figure, based partly on mortality and serosurvey data (which purports to show the percentage of antibodies in the population, data that has been collected and relied upon by India's public health authorities).

Of course, as we noted above, it's not just India. The WHO believes the true number of COVID-19 cases around the world is 2x to 3x higher than the official tally.

But India's undercounting of deaths is especially severe because overwhelmed hospitals started turning away patients during the April-May outbreak, leaving many to die in their homes are cars. Many of these patients weren't counted because their deaths didn't take place in a hospital, but at home, without them ever being tested for COVID.

Several Indian states have set up compensation funds to help families that lost loved ones during the pandemic. However, these funds typically require proof that the death was caused by COVID-19, leaving thousands of families effectively shut out of one of the most reliable sources of government support.

In the village of Sirondhan in the northern state of Uttar Pradesh, for example, Vijay Pal Singh said his 38-year-old wife, Mithilesh Devi, fell ill last month with a fever and struggled to breathe. Mr. Singh said he took her to the village clinic and several hospitals in the district, but none had available beds or testing kits.
"She died at home, gasping for oxygen," Mr. Singh said. Her death wasn't included in the official Covid-19 tally, he added.
At least 30 people died in the village in late April and early May, many suffering from Covid-like symptoms, according to villagers and social workers. A further 47 died in two neighboring villages.
Villager Dharamvir Singh said one or two people died almost every day during the worst weeks of the second wave. He says he believes he and four members of his family were infected. No one was tested.
"The official numbers, at least for our village and a few others close to us, are totally wrong," Mr. Singh said.


Government officials in the state insist that the official numbers are correct, and that there are no plans to expand or revise the tallies. This shouldn't come as a surprise, since Prime Minister Narendra Modi's government praises states with lower numbers while castigating states with higher numbers. While some states and cities have adjusted their tallies, the official numbers likely remain far below the true figures. A recent investigation in the state of Bihar found nearly 4,000 more Covid-19 deaths, raising its toll by over 72%.

At the very least, more communities across India are resorting to COVID prophylactics like Ivermectin, measures that have apparently helped India to finally bring its outbreak under control.



To: sense who wrote (173902)6/29/2021 4:17:59 AM
From: TobagoJack2 Recommendations

Recommended By
maceng2
sense

  Respond to of 217580
 
Re <<Thus far, there doesn't appear to be a lot of evidence suggesting Delta variants are any more problematic than those before them in terms of overall health impacts... >>

facts did not matter in the past and therefore shouldn't matter, never mind the truth, whatever the truth be

today's in-tray item re Europe open

Wall Street's big banks are rewarding investors after passing the Fed's stress tests. Morgan Stanley doubled quarterly dividends and plans up to $12 billion in buybacks. Wells Fargo has an $18 billion buyback program. Goldman, JPMorgan and BofA are also boosting dividends. Citi was the outlier with no planned raise. The payouts surge may raise the ire of politicians over perceptions they enrich executives.

Asian stocks fell on concerns the more contagious delta Covid strain will derail an economic recovery as lockdowns and restrictions tighten. U.S. and FTSE 100 futures also dipped. Treasuries slipped and the dollar were steady. The pound weakened. Brent extended a decline on expectations OPEC+ producers will decide this week to increase supply. Bitcoin was steady.

Add this to British travelers' woes: Hopes are fading that the U.K. and U.S. will agree to open a travel corridor before the end of the summer, the FT reported. "It's looking more like September," one official said. The U.K. was reported to be pushing for a pact far more than the U.S. The news may dent market hopes that new Health Secretary Sajid Javid's appointment might spur reopening.

Virus: More than 12 million Australians, close to half of the population, are now in lockdown after Brisbane became the country's fourth regional capital city to restrict movement to contain a spread of the delta variant. Los Angeles County strongly recommended people wear masks indoors in public places, regardless of vaccination status, to protect against the variant. The U.S. increased its travel warning for the UAE and four African countries to the highest risk level.

Facebook's market value surged past $1 trillion after it won the dismissal of two U.S. antitrust cases. The ruling is a blow to the FTC and a coalition of states that claimed it broke competition laws by buying Instagram and WhatsApp to protect its monopoly. Elsewhere, DOJ investigators recently stepped up scrutiny of Google's digital ad market practices, people familiar said, in a sign the Biden administration is actively pursuing a probe that began under the previous administration.

AutoStore is weighing an IPO that could value the Norwegian warehouse robotics company at more than $10 billion, people familiar said. The company is working with advisers on the planned listing, which could take place in Europe this year.

Goldman, former CEO Lloyd Blankfein and former COO Gary Cohn must face a shareholder lawsuit over the 1MDB bribery scandal after a ruling by a Manhattan judge denied their motions to dismiss the suit, which is led by Swedish pension fund Sjunde AP-Fonden. Former co-COO Harvey Schwartz was dropped from the case.

Joe Biden told Israel President Reuven Rivlin that Iran will never get a nuclear weapon and the U.S. remains determined to counter Tehran's "malign activity and support for terrorist proxies." This was after the president defended U.S. airstrikes on Iran-backed militias in Iraq and Syria, pushing back against members of Congress who questioned whether they should have been consulted in advance. U.S. troops came under rocket fire in Syria yesterday without suffering casualties.

Crypto roundup:

The Fed's Randal Quarles expressed caution about rushing to issue a central bank digital currency, saying the benefits are "unclear" while posing "significant and concrete risks."

Cathie Wood's ARK Investment filed to create a Bitcoin ETF.

Coinbase said people should not "take being listed on Coinbase as an endorsement of that asset."

European data: Germany's HICP inflation rate is likely to slow significantly to 1.8% in June, Bloomberg Economics said. Consensus is for a 2.1% pace. Spain's rate is seen unchanged at 2.4%. U.K.'s Nationwide house price survey is expected to show year-on-year growth of 13.6% for June.

Chart of the Day: Renault, the worst performing mass-market carmaker on the Stoxx 600 Automobiles & Parts Index, may get investor attention with its EV strategy event tomorrow. After being an early battery-EV champion with the Zoe model, its market share has been squeezed. It's recently signed production-minded deals, including one with Envision Group for a battery plant, as it prepares to take a deep dive into EV technologies.